Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
03320 CHINARES PHARMA
RT Nominal up5.540 +0.120 (+2.214%)
Latest  |  Final  |  Interim
Non-current Assets
2023/12 - Final
RMB(K¥)
%Chg
(Final to Final)
2022/12
RMB(K¥)
2021/12
HKD(K$)
2020/12
HKD(K$)
2019/12
HKD(K$)
Investment Properties1,692,20613.406%1,492,1681,887,0341,935,9101,724,234
Property, plant, equip. & others20,117,61515.871%17,362,07819,676,74317,324,38916,322,310
Land & other Lease Assets4,925,15913.602%4,335,4355,361,3925,317,8495,507,549
Intangible Assets29,471,0365.350%27,974,49733,902,06128,011,82525,355,635
Interests in Asso. & JCEs6,037,0472.144%5,910,3436,873,3985,732,1124,832,090
Other Non-current Assets5,959,403-3.886%6,200,3594,252,0733,940,8183,340,579

68,202,4667.788%63,274,88071,952,70162,262,90357,082,397
Current Assets
2023/12 - Final
RMB(K¥)
%Chg
(Final to Final)
2022/12
RMB(K¥)
2021/12
HKD(K$)
2020/12
HKD(K$)
2019/12
HKD(K$)
Inventories31,875,48720.073%26,546,65229,687,99224,584,76122,332,374
Trade Receivables68,063,39812.368%60,571,91467,142,61058,627,54454,118,904
Cash & Bank Balances24,650,67061.923%15,223,72617,513,13411,231,49712,524,016
Other Current Assets53,939,7118.157%49,871,66362,265,87352,665,05543,967,322
Assets Held for Sale38,564-15.315%45,538000

178,567,83017.279%152,259,493176,609,609147,108,857132,942,616
Current Liabilities
2023/12 - Final
RMB(K¥)
%Chg
(Final to Final)
2022/12
RMB(K¥)
2021/12
HKD(K$)
2020/12
HKD(K$)
2019/12
HKD(K$)
Trade Payables54,451,02111.783%48,711,22452,272,84745,602,09242,731,056
S-T Debt & Leases46,223,58925.611%36,799,01548,434,61540,991,87030,389,032
Other Current Liabilities33,558,145-7.451%36,259,82940,615,11436,025,69333,551,581
Liab asso w/ Assets Held for Sale0--0000

134,232,75510.235%121,770,068141,322,576122,619,655106,671,669
Net Current Assets44,335,07545.411%30,489,42535,287,03324,489,20226,270,947
Total Assets Less Current Liabilities112,537,54120.022%93,764,305107,239,73486,752,10583,353,344
Non-current Liabilities
2023/12 - Final
RMB(K¥)
%Chg
(Final to Final)
2022/12
RMB(K¥)
2021/12
HKD(K$)
2020/12
HKD(K$)
2019/12
HKD(K$)
L-T Debt & Leases15,937,37262.425%9,812,1688,113,0913,163,50910,876,407
Other Non-current Liabilities3,625,3556.792%3,394,7934,142,3773,559,1522,895,116

19,562,72748.124%13,206,96112,255,4686,722,66113,771,523
Capital and Reserves
2023/12 - Final
RMB(K¥)
%Chg
(Final to Final)
2022/12
RMB(K¥)
2021/12
HKD(K$)
2020/12
HKD(K$)
2019/12
HKD(K$)
  Share Capital24,630,4930.000%24,630,49327,241,28927,241,28927,241,289
  Reserves21,329,11212.694%18,926,54123,740,19819,228,53713,470,059
  Others0--0000
Shareholders' Funds45,959,6055.516%43,557,03450,981,48746,469,82640,711,348
Non-controlling Interests47,015,20927.067%37,000,31044,002,77933,559,61828,870,473
Others0--0000

92,974,81415.414%80,557,34494,984,26680,029,44469,581,821
Commitments and Contingent Liabilities
2023/12 - Final
RMB(K¥)
%Chg
(Final to Final)
2022/12
RMB(K¥)
2021/12
HKD(K$)
2020/12
HKD(K$)
2019/12
HKD(K$)
Commitments------590,022967,2922,003,043
Contingent Liabilities------8,791,69316,861,74818,586,719
Remarks:  Real time quote last updated: 22/07/2024 13:17
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
Security Code
Company Name (Chi/Eng/Keywords)
Industry
Profit / (Loss) Attributable to Shareholders (K¥)RMB 3,854,247
%Change10.113%
EPS / (LPS)RMB 0.610
NBV Per Share (¥)RMB 7.315
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2024 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.